|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Sales (Note 1) | |||||
| Cost of Sales | |||||
| Gross Profit | |||||
| Operating Expenses: | |||||
| Selling (Note 1) | |||||
| Administrative (Note 1) | |||||
| Research, development and technical services (Note 1) | |||||
| Deferred compensation expense (Note 12) | |||||
| Total Operating expenses | |||||
| Goodwill and other intangibles impairment (Note 4) | |||||
| Business restructuring and assets impairment (Note 22) | |||||
| Gain on sales of assets (Note 20) | |||||
| Operating Income | |||||
| Other Income (Expense): | |||||
| Interest, net (Note 6) | |||||
| Other, net (Note 8) | |||||
| Nonoperating Income (Expense), Total | |||||
| Income Before Provision for Income Taxes | |||||
| Provision for Income Taxes (Note 9) | |||||
| Net Income | |||||
| Net Income Per Common Share (Note 18): | |||||
| Basic | |||||
| Diluted | |||||
| Shares Used to Compute Net Income Per Common Share (Note 18): | |||||
| Basic | |||||
| Diluted | |||||
Loading...